U.S., Dec. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07281352) titled 'RCT of Psilocybin-assisted CBT for Depression' on Dec. 08.
Brief Summary: The primary objectives of this clinical investigation are to (1) determine the acceptability and feasibility of joining psilocybin-assisted therapy with cognitive-behavioral therapy (PA-CBT) for patients with depression, (2) optimize CBT to most effectively integrate the psilocybin experience with psychotherapy and (3) examine the clinical benefit of psilocybin as an adjunct to cognitive-behavioral therapy (CBT) for major depressive disorder.
This study is a randomized, two-arm, fixed dose trial that will test the feasibility, acceptability, and participant a...